Member Info for Bluelight

Vallances comments just now... He also adds that the testing programme may become "very stretched". AKA, cash in the bank for NCYT, get that phone out, put your grovelling pants n and see if NCYT are willing to do more business with you...

Indeed it is, feels like sentiment has returned here. Should be good for the whole covid testing sector over coming months heading into winter. just look at those videos of nightblubs packed to the rafters with no masks. We are entering a golden age for testing, not so golden for the vulnerable and elderly though...

New PI's will come in when the price starts rising, most private investors are sheep. true they'll miss out on the big gains, but most only want short term gains. It's mostly self fulfilling, what works on a slide down, works on a rally up.

Just way until 3:30pm covidop, that's when our french chums go on their daily buying spree.

No need for an RNS for the price to move up now. We are heavily underpriced now as we stand, any additional RNS's are just gravy. Some other companies need a daily RNS to support the price, we I believe are now in the sweet spot before the rally higher.

Its a tricky one to forecast specifically for sure. But generically though, if you have twice the demand you expected for PCR (and personally I can see it getting to 600k plus in a few weeks) then you are going to run down your stocks pretty sharpish. I don't think the DHSC foresaw this summer surge and end to all lockdown/restrictions when they decided to hold back on orders and payments, puts them in an incredibly tricky situation now. Great for our negotiating position and future orders mind you.

On that point, in the April update they stated the q1 promote sales may be enough to cover the dhsc for the year. Pcr testing was average 200k a day then, it's pushing to 500k a day now. So at 200k that's 8m of stock, at 500k that's just over 3m stock (assuming promote ratio of use is consistant). If that's correct then they will have used all the promote around August (I've added a month on as we've been ramping up to 500k). So I'd think we should see a new order this month with turnaround and delivery times.

Can't be long until they use up all the promote at 500k pcr tests a day. New order incoming soon I'd suspect

Wouldn't be a weekend without the lft folks getting excited about something, just gives the shorters more ammunition at the start of a new week when nothing appears.

54674 cases today and one of the highest ever daily PCR tests undertaken...

You are not insane Ravenox, you are just among the first few to realise the situation we are in and to take advantage of it by owning Nova shares.

Soder it's ok, the outer hebrides still has a low infection rate which if you interpolate for the rest of the UK means that we don't have any problem, the data never lies ;) Lets all take our masks off and go clubbing on Monday, free love.

Worryingly the hospital admission rate is shooting up too now, over 700 daily now and thats with a 5 day lag...

Plus the interest those unpaid invoices will have accrued, as their will be a payment default penalty in the contract, probably libor plus x%.

@Jgcw, you are a cheery soul aren't you. Don't think I've ever seen a positive post from you, cheer up its nearly the weekend.

I think the horse has already bolted there, 50k infections a day, 0.5m people told to self isolate a day.. If that's not already bad I'd hate to see it when it is.

Puts the uk cases into perspective, we are around 10% of the total world infections! But don't worry, it's appreciated if you'd ever so kindly wear a mask from next week, if its not too much bother.

And yet NCYT trading at the bottom of its range, couldn't make it up. The media's woken up to it, time potential investors did. Just need a spark, whether that's an rns or a sudden sentiment shift who knows, but must be time. Share prices can only ignore fundamentals for so long.

Worth noting they expected testing to only pick up in q4, yet we are in july and testing is through the roof already. That's millions more revenue alone

Here's your H1 update, £5.40 tomorrow then? For the five months ended 31 May 2021, the Company had unaudited sales of £88.4m compared to £40.8m for the same period in 2020. This £88.4m includes £40.7m of sales to the DHSC, which are part of the dispute. Excluding the DHSC, the Company saw a run-rate of over £10m in sales per month in Q1 2021, which has declined to approximately £7m per month in April and May as infection rates eased and testing has dropped sharply. This is a repeat of the trend seen in 2020 as countries moved into the summer period and the spread of COVID-19 declined.

Looking forward, the Company expects strong growth in private testing as markets and travel re-open, which could lead to higher infection rates, and an increase in testing to return in Q4 2021, in line with Q4 2020, during the winter period. The Company also expects to see significant new growth from the launch of new products during the second half of 2021, including an expansion of its lateral flow antigen testing portfolio for both professional and home use. If demand picks up in line with expectations, the Company expects to see full year sales of approximately £100m, excluding the sales to the DHSC which are in dispute.

In the first five months of 2021, Novacyt has delivered a gross margin of over 70% and an EBITDA margin of over 40%